PL1971339T3 - Połączenie pochodnych triazyny i środków stymulujących wydzielanie insuliny - Google Patents

Połączenie pochodnych triazyny i środków stymulujących wydzielanie insuliny

Info

Publication number
PL1971339T3
PL1971339T3 PL06829703T PL06829703T PL1971339T3 PL 1971339 T3 PL1971339 T3 PL 1971339T3 PL 06829703 T PL06829703 T PL 06829703T PL 06829703 T PL06829703 T PL 06829703T PL 1971339 T3 PL1971339 T3 PL 1971339T3
Authority
PL
Poland
Prior art keywords
combination
insulin secretion
triazine derivatives
secretion stimulators
stimulators
Prior art date
Application number
PL06829703T
Other languages
English (en)
Inventor
Gérard Moinet
Daniel Cravo
Didier Mesangeau
Original Assignee
Poxel Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel Sas filed Critical Poxel Sas
Publication of PL1971339T3 publication Critical patent/PL1971339T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06829703T 2006-01-13 2006-12-18 Połączenie pochodnych triazyny i środków stymulujących wydzielanie insuliny PL1971339T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0600342A FR2896157B1 (fr) 2006-01-13 2006-01-13 Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
EP06829703A EP1971339B1 (en) 2006-01-13 2006-12-18 Combination of triazine derivatives and insulin secretion stimulators
PCT/EP2006/012182 WO2007079914A2 (en) 2006-01-13 2006-12-18 Combination of triazine derivatives and insulin secretion stimulators

Publications (1)

Publication Number Publication Date
PL1971339T3 true PL1971339T3 (pl) 2012-04-30

Family

ID=36648317

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06829703T PL1971339T3 (pl) 2006-01-13 2006-12-18 Połączenie pochodnych triazyny i środków stymulujących wydzielanie insuliny

Country Status (21)

Country Link
US (1) US8227465B2 (pl)
EP (1) EP1971339B1 (pl)
JP (1) JP5702911B2 (pl)
KR (1) KR20080091366A (pl)
CN (1) CN101355949A (pl)
AR (1) AR059030A1 (pl)
AT (1) ATE540682T1 (pl)
AU (1) AU2006334731B2 (pl)
BR (1) BRPI0620923A2 (pl)
CA (1) CA2636837C (pl)
CY (1) CY1112674T1 (pl)
DK (1) DK1971339T3 (pl)
EA (1) EA016649B1 (pl)
ES (1) ES2378469T3 (pl)
FR (1) FR2896157B1 (pl)
IL (1) IL192596A (pl)
PL (1) PL1971339T3 (pl)
PT (1) PT1971339E (pl)
SI (1) SI1971339T1 (pl)
WO (1) WO2007079914A2 (pl)
ZA (1) ZA200806938B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2530223T3 (es) 2008-12-12 2015-02-27 Poxel S.A.S. Combinación de insulina con derivados de triazina y su uso para tratar la diabetes
FR2948028B1 (fr) * 2009-07-17 2011-12-02 Merck Sante Sas Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine
RU2550798C2 (ru) * 2011-05-12 2015-05-10 Василий Иосифович Зоря Способ стимуляции секреции инсулина
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
TWI748945B (zh) * 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
EP3691650A1 (en) 2017-10-02 2020-08-12 Poxel Methods of treating heart failure with preserved ejection fraction
MY203360A (en) 2018-06-06 2024-06-26 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
CA3103324A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
USD945167S1 (en) 2018-10-31 2022-03-08 Kimberly-Clark Worldwide, Inc. Paper sheet
KR20220113942A (ko) * 2019-12-13 2022-08-17 스미토모 파마 가부시키가이샤 제조성 및 용출성이 우수한 소형 정제
US12280125B2 (en) 2022-09-09 2025-04-22 Imam Abdulrahman Bin Faisal University Method for delivering insulin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
SI1133312T1 (sl) * 1999-06-21 2008-02-29 Lilly Co Eli Uporaba tiazolidindionov v kombinaciji z glukagonu podobnim peptidom-1 in njegovimi agonisti za zdravljenje sladkorne bolezni, neodvisne od inzulina
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
ATE385421T1 (de) * 2000-01-21 2008-02-15 Novartis Pharma Gmbh Zusammensetzungen bestehend aus dipeptidylpeptidase-iv inhibitoren und antidiabetica
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
ITFI20010126A1 (it) 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
ATE361065T1 (de) * 2002-01-25 2007-05-15 Silanes Sa De Cv Lab Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US20040147564A1 (en) * 2003-01-29 2004-07-29 Rao Vinay U. Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
AU2004267955A1 (en) * 2003-09-02 2005-03-10 Prosidion Ltd. Combination therapy for glycaemic control

Also Published As

Publication number Publication date
BRPI0620923A2 (pt) 2011-11-29
CY1112674T1 (el) 2016-02-10
CA2636837C (en) 2013-12-10
US20100233255A1 (en) 2010-09-16
SI1971339T1 (sl) 2012-07-31
FR2896157A1 (fr) 2007-07-20
ATE540682T1 (de) 2012-01-15
IL192596A0 (en) 2009-09-22
EA200801665A1 (ru) 2008-12-30
AU2006334731B2 (en) 2012-06-21
DK1971339T3 (da) 2012-02-20
JP2009523139A (ja) 2009-06-18
IL192596A (en) 2015-07-30
US8227465B2 (en) 2012-07-24
ES2378469T3 (es) 2012-04-12
WO2007079914A2 (en) 2007-07-19
EP1971339A2 (en) 2008-09-24
PT1971339E (pt) 2012-02-20
CN101355949A (zh) 2009-01-28
AU2006334731A1 (en) 2007-07-19
AR059030A1 (es) 2008-03-12
EP1971339B1 (en) 2012-01-11
JP5702911B2 (ja) 2015-04-15
ZA200806938B (en) 2010-02-24
WO2007079914A3 (en) 2007-09-07
CA2636837A1 (en) 2007-07-19
KR20080091366A (ko) 2008-10-10
EA016649B1 (ru) 2012-06-29
FR2896157B1 (fr) 2008-09-12

Similar Documents

Publication Publication Date Title
ZA200806938B (en) Combination of triazine derivatives and insulin secretion stimulators
EP2164433A4 (en) ANCHORED RESPIRATORY TRACT IMPLANTS AND METHODS USING THE SAME
ZA201001051B (en) Benzylbenzene derivatives and methods of use
IL194975A0 (en) Composition and methods for treatment of congestive heart failure
IL204562A0 (en) Piperidine and piperazine derivatives for the treatment of tumours
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
IL196243A0 (en) Fused heterocyclic derivatives and methods of use
EP1971294A4 (en) IMPLANTABLE JOINT PROSTHESIS
IL209282A0 (en) Heterocyclic compound and use thereof
IL193198A0 (en) Long-actine polypeptides and methods of producing and administering same
ZA200806947B (en) Combination of triazine derivatives and insulin sensitisers
ZA201007059B (en) Quinoxalinone derivatives as insulin secretion stimulators,methods for obtaining them and use thereof for the treatment of diabetes
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
IL196469A0 (en) New medical use of triazine derivatives
TWI372762B (en) Amino derivatives of b-homoandrostanes and b-heteroandrostanes
ZA200809112B (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
EP2077797A4 (en) IMPLANTABLE DEVICES AND METHODS OF FORMATION THEREOF
ZA200806936B (en) Combination of triazine derivatives and pparoagonists
ZA200810757B (en) Novel glucokinase activators and methods of using same
PL383162A1 (pl) N-alkilowe pochodne 2-amino-2-deoksy -D-glukitolo-6-fosforanu i sposób ich otrzymywania
GB0500477D0 (en) New Medical use of triazine derivatives
PL384200A1 (pl) Terapia skojarzona z zastosowaniem glikokortykosteroidu i pochodnej cholekalcyferolu
IL194758A0 (en) N-oxides of pyridylmethylpipertazine and-piperidine derivatives
IL198709A0 (en) Nitrogen-containing heterocyclic compounds and methods of use thereof